The Preventing Pressure Ulcers market outlook remains robust, driven by aging populations, rising chronic disease prevalence, and stringent healthcare regulations prioritizing patient safety. Market attractiveness is underscored by untapped potential in emerging economies and the growing emphasis on hospital-acquired condition prevention. Competitive intensity is moderate, with key players leveraging R&D investments in advanced wound care materials and smart monitoring technologies, while new entrants face high regulatory and capital barriers. The long-term outlook is optimistic, with sustained demand projected through 2030, fueled by demographic shifts and increasing adoption of evidence-based prevention protocols. The innovation landscape is dynamic, marked by advancements in antimicrobial dressings, IoT-enabled pressure-mapping systems, and AI-driven risk assessment tools. However, demand–supply balance remains uneven, with shortages in low-resource regions and oversupply in saturated markets. Key risk factors include stringent reimbursement policies, litigation risks from product failures, and fluctuating raw material costs. Strategic partnerships and geographic expansion will be critical for stakeholders to navigate these challenges.